Key Points
- This research aims to explore how specific variants of the angiotensinogen gene relate to hypertension and plasma AGT levels in Nigerians.
- Selected participants from a survey of 2509 individuals aged 25 to 74 years.
- Hypertensive subjects defined by high blood pressure or antihypertensive medication; controls by low blood pressure with no medication.
- Analyses focused on the association between M235T variant, plasma AGT levels, and hypertension status.
- Hypertensive subjects had significantly higher plasma AGT levels compared to controls (exact values not specified).
- A significant association was found between the M235T variant and plasma AGT level.
- Allele frequencies for M235T and T174M variants did not significantly differ between hypertensive and control subjects.
Structured PICO
Are the M235T and T174M variants of the AGT gene associated with plasma AGT levels and hypertension status in Nigerians?
PPopulationNigerians aged 25 to 74 years selected from the extremes of blood pressure distribution from a population survey of 2509 individuals. Cases had high blood pressure or took antihypertensive medication; controls had low blood pressure and never took antihypertensive medication.
IInterventionM235T and T174M variants of the angiotensinogen (AGT) gene
CComparatorControl subjects with low blood pressure / wild-type alleles
OOutcomeAssociation between AGT gene variants, plasma AGT levels, and hypertension statussurrogate
The M235T variant of the AGT gene is associated with plasma AGT levels, which are elevated in hypertensive Nigerians, supporting a biochemical link between renin-angiotensin system genetics and hypertension.